17-29250316-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005208.5(CRYBA1):​c.215+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.031 in 1,374,546 control chromosomes in the GnomAD database, including 822 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.040 ( 170 hom., cov: 32)
Exomes 𝑓: 0.030 ( 652 hom. )

Consequence

CRYBA1
NM_005208.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.184

Publications

4 publications found
Variant links:
Genes affected
CRYBA1 (HGNC:2394): (crystallin beta A1) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta acidic group member, encodes two proteins (crystallin, beta A3 and crystallin, beta A1) from a single mRNA, the latter protein is 17 aa shorter than crystallin, beta A3 and is generated by use of an alternate translation initiation site. Deletion of exons 3 and 4 causes the autosomal dominant disease 'zonular cataract with sutural opacities'. [provided by RefSeq, Jul 2008]
CRYBA1 Gene-Disease associations (from GenCC):
  • cataract 10 multiple types
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • early-onset lamellar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset posterior polar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset sutural cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 17-29250316-C-T is Benign according to our data. Variant chr17-29250316-C-T is described in ClinVar as [Benign]. Clinvar id is 259671.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0782 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRYBA1NM_005208.5 linkc.215+16C>T intron_variant Intron 3 of 5 ENST00000225387.8 NP_005199.2 P05813-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRYBA1ENST00000225387.8 linkc.215+16C>T intron_variant Intron 3 of 5 1 NM_005208.5 ENSP00000225387.3 P05813-1
CRYBA1ENST00000484605.1 linkn.203+16C>T intron_variant Intron 3 of 4 5 ENSP00000464368.1 J3QRT1

Frequencies

GnomAD3 genomes
AF:
0.0400
AC:
6075
AN:
152032
Hom.:
168
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0803
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0261
Gnomad ASJ
AF:
0.0133
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0185
Gnomad FIN
AF:
0.0186
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0283
Gnomad OTH
AF:
0.0307
GnomAD2 exomes
AF:
0.0262
AC:
6590
AN:
251394
AF XY:
0.0254
show subpopulations
Gnomad AFR exome
AF:
0.0811
Gnomad AMR exome
AF:
0.0157
Gnomad ASJ exome
AF:
0.0138
Gnomad EAS exome
AF:
0.000435
Gnomad FIN exome
AF:
0.0211
Gnomad NFE exome
AF:
0.0289
Gnomad OTH exome
AF:
0.0253
GnomAD4 exome
AF:
0.0298
AC:
36462
AN:
1222396
Hom.:
652
Cov.:
18
AF XY:
0.0293
AC XY:
18131
AN XY:
619716
show subpopulations
African (AFR)
AF:
0.0826
AC:
2405
AN:
29132
American (AMR)
AF:
0.0169
AC:
752
AN:
44410
Ashkenazi Jewish (ASJ)
AF:
0.0144
AC:
354
AN:
24618
East Asian (EAS)
AF:
0.000207
AC:
8
AN:
38606
South Asian (SAS)
AF:
0.0218
AC:
1777
AN:
81564
European-Finnish (FIN)
AF:
0.0198
AC:
1055
AN:
53324
Middle Eastern (MID)
AF:
0.0352
AC:
182
AN:
5176
European-Non Finnish (NFE)
AF:
0.0320
AC:
28567
AN:
892988
Other (OTH)
AF:
0.0259
AC:
1362
AN:
52578
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1576
3152
4727
6303
7879
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1046
2092
3138
4184
5230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0400
AC:
6090
AN:
152150
Hom.:
170
Cov.:
32
AF XY:
0.0385
AC XY:
2861
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0805
AC:
3339
AN:
41474
American (AMR)
AF:
0.0261
AC:
399
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0133
AC:
46
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.0187
AC:
90
AN:
4814
European-Finnish (FIN)
AF:
0.0186
AC:
197
AN:
10612
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0283
AC:
1925
AN:
68004
Other (OTH)
AF:
0.0299
AC:
63
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
295
590
885
1180
1475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0330
Hom.:
18
Bravo
AF:
0.0412
Asia WGS
AF:
0.0120
AC:
43
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cataract 10 multiple types Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.2
DANN
Benign
0.62
PhyloP100
-0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72819448; hg19: chr17-27577334; API